HAVIT Blog

Science-backed guides on habits, sleep, nutrition, and movement.

LatestBest Calorie Counter Apps in 2026 (Free and Paid): Every Major App, Reviewed One by OneEvery number in a calorie app is an estimate, so choose on consistency rather than claimed accuracy. Data provenance matters more than database size — and check what happens after the number.

All articles

Semaglutide Tracker: What to Track (Ozempic, Wegovy, Rybelsus)

A semaglutide tracker logs your dose, injection site or pill timing, weight trend, protein & side effects across Ozempic, Wegovy & Rybelsus. Here's what to track.

Shotsy Alternative for GLP-1 Users: An Honest 2026 Comparison — HAVIT vs Shotsy

Looking for a Shotsy alternative on Ozempic or Zepbound? What Shotsy's shot tracker does well, where it stops, and how an all-in-one GLP-1 app compares.

Tirzepatide Side Effects: Mounjaro & Zepbound (2026)

The most common tirzepatide side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying, which need urgent medical care.

Wegovy Side Effects: Nausea, Hair Loss & Timeline (2026)

Wegovy's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild and worst during dose increases. Because Wegovy titrates to a higher 2.4 mg dose, these are reported more often than with Ozempic. Rare but serious risks include pancreatitis, gallbladder disease, and severe delayed stomach emptying.

WeightWatchers GLP-1 Alternative: An Honest 2026 Comparison — HAVIT vs WeightWatchers

Looking for a WeightWatchers GLP-1 alternative? What WW's Points program and WeightWatchers Clinic do well, where they leave gaps, and how to choose a tracker.

Zepbound Tracker: What to Track on Zepbound & How (2026)

A Zepbound tracker logs your dose date, injection site, weight trend, protein & side effects. Learn exactly what to track on tirzepatide and why it matters.

GLP-1 Alone Is Not Enough — The "Drug + Behavioral Therapy" Model Recommended by WHO/ADA, and HAVIT's M0/M1/M2 Stages

GLP-1 receptor agonists (Wegovy, Mounjaro, Zepbound) produce 15–22% average weight loss (STEP 1, SURMOUNT-1). But STEP 4 reported +11.6%p regain one year after discontinuation — about 78% of weight loss returned. WHO (2022) and ADA Standards (2024) explicitly recommend behavioral therapy alongside pharmacotherapy, and STEP 3 (JAMA 2021) showed Intensive Behavioral Therapy in combination achieved nearly 3× the weight loss of standard-care combination (−16% vs −5.7%). HAVIT structures this in 3 stages — pre-medication (M0), adaptation (M1), maintenance/discontinuation (M2) — integrating drugs, muscle preservation, and behavior learning. HAVIT does not prescribe GLP-1; prescription, dosing, and discontinuation remain the physician's domain.

Democratizing Body Composition Checks — How HAVIT's Survey-Based Model Achieves Clinical-Tool-Grade Accuracy (n=70 Internal Comparison Study Using InBody as Reference)

Effective obesity and metabolic-health management starts from an accurate body composition baseline. Standard tools (DEXA, InBody) carry a three-way barrier — costly, in-person, expensive per use. HAVIT estimates body fat %, muscle mass, visceral fat, BMR, TDEE, WHtR, and biological age from smartphone survey + basic body info (height, weight, sex, age) alone. n=70 internal comparison vs InBody: ±5% agreement 92.9%, MAE 2.42%p, CCC 0.93, statistically significant over the Deurenberg standard formula across 6 indicators (Steiger Z p=0.030). The goal is democratizing body composition checks for non-clinical daily tracking — anyone, anywhere, anytime, without additional equipment. HAVIT is not a medical diagnostic tool.

The New Standard for Digital Health Coaching — How HAVIT's 8-Step AI Coaching Engine Integrates Personalization, Immediate Feedback, and Behavior Triggers

Most health apps deliver static prescriptions like 'eat 1,500 kcal today.' But the literature shows digital behavioral intervention effectiveness scales with personalization · feedback immediacy · behavior triggers (Tate 2003 JAMA; Patel 2015 Ann Intern Med). HAVIT's 8-step coaching engine is built on the Fogg Behavior Model (B = M × A × P) and Self-Determination Theory (autonomy · competence · relatedness), matching prescriptions from 126 archetypes × 2,000+ behavior library to changing user signals each moment. HAVIT is not a medical diagnostic tool; clinical diagnosis and treatment decisions are the physician's domain.

Beyond BMI — Why the New Generation of Diet Apps Needs Body Composition, Lifestyle Data, and Personalized Behavior Change (HAVIT vs MyFitnessPal vs Noom vs Simple.Life)

The science of obesity management has changed: body composition + lifestyle + personalized behavior beats BMI-only tracking, per DPP/Look AHEAD/STEP trials and WHO/ADA guidance. HAVIT integrates AI body composition estimation (n=70 InBody-reference internal study, 92.9% ±5% agreement), 126-archetype personalization, and GLP-1-aware behavior coaching as a Gen-4 assessment+coaching model — versus MyFitnessPal (tracking), Noom (CBT coaching), and Simple.Life (AI fasting). HAVIT is not a medical diagnostic tool.

What Is K-Wellness — Why the Integrated Measurement·Assessment·Lifestyle Model Is Becoming the New Global Wellness Standard

K-Wellness is not a marketing label. It is the systematized integrated model — quantitative measurement → multi-marker assessment → personalized prescription → lifestyle coordination — validated through 12-week transformation programs at Korean metabolic clinics. This model lines up precisely with the academic standard: BMI limits, body composition + lifestyle assessment, personalized behavior prescription — Ross 2020, DPP, Look AHEAD, Wing & Phelan all point the same direction. HAVIT is the digital entry point that makes this methodology accessible to US and global users. HAVIT is a non-clinical daily tracking tool.

Why Your 30-Day Habit Challenge Will Probably Fail (And What Actually Works)

30-day challenges fail most people because they ignore how habits actually form—try micro-challenges or the 66-day graduated approach instead.